AmeraCell Revolutionizes Cellular Health with Breakthrough Treatment Combining NAD+ and MSC
United States, 26th Mar 2025 – AmeraCell, a pioneering regenerative medicine company, is proud to announce a groundbreaking new treatment that harnesses the synergistic power of Nicotinamide Adenine Dinucleotide (NAD+) and Mesenchymal Stem Cells (MSC) to promote cellular health and…